Glen Wunderlich

1PUBLICATIONS
0CO-AUTHORS
Memory and attention
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 27, 2023
Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia.

Holger Rosenbrock, Michael Desch, Glen Wunderlich

Pageof 1

Frequent Collaborators